RSCM
FRTX

Rock Springs Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Rock Springs Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-581
Closed -$1.28M – 128
2015
Q2 		$1.28M Buy
+581
New +$1.82M 0.09% 115

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rock Springs Capital Management's FRTX Position: Q3 2015 in Review

Rock Springs Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2015, closing a stake of 581 shares — an estimated $1.28M sold.

Rock Springs Capital Management first reported a position in FRTX in Q2 2015 and held it in 1 quarter. The position peaked at $1.28M in Q2 2015. 49 funds tracked by Wall St. Rank hold FRTX as of Q3 2015.

  • Rock Springs Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 581 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $1.28M.
  • Rock Springs Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Rock Springs Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $1.28M in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Rock Springs Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.